Molecular Devices’ stock lost 16.9 percent of its value for the trading week ended Tuesday, following last week’s announcement that it was lowering its revenue guidance for the third quarter (see related article). The firm led all eight decliners for the trading period. Meanwhile, Stratagene shares gained 10.7 percent to lead all issues in the BCW Index.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.